Sources Sought
JADA System (postpartum hemorrhage control device)
Department of Health and Human Services · Indian Health Service · Sol. IHS102027
Due in 7 daysBuy Indian Set-Aside (specific to Department of Health and Human Services, Indian Health Services)
AI summary Beta
Some details are in the notice's attachments, which this summary didn't read. Check the attachments on SAM.gov.
This is a Sources Sought notice (not a solicitation) from the Indian Health Service, looking for Indian Small Business Economic Enterprises and other small businesses that can supply the JADA System postpartum hemorrhage control device, or an equivalent FDA-cleared successor product, for delivery to IHS distribution centers in Oklahoma City, OK and Gallup, NM.
Watch out for
- Submission instructions not shown in this text. The notice says instructions for submission are 'outlined below' but no email or portal address actually appears in the visible text, so you may need to check attached files or the SAM.gov listing directly.
Instructions for submission are outlined below.
- Generic capability statements will be rejected. IHS explicitly warns that generic capability statements won't be enough; you need to show direct experience with this specific device or an equivalent.
firms should understand that generic capability statements are not sufficient for effective evaluation of their capacity and capability to perform the work required.
Read from the notice text only.
Full brief
What they want
- Submit a capability statement demonstrating direct experience providing the JADA System or an equivalent FDA-cleared successor product
- Submit the attached Buy Indian Act Indian Economic Enterprise Representation Form
- Be able to deliver to NSSC Distribution Center and NSSC I-35 (Oklahoma City, OK) and NSSC-Gallup (Gallup, NM)
- Place of performance
- Oklahoma City, OK, USA (deliveries also go to Gallup, NM)
- Offers due
- October 5, 2026 by 2:00 PM Central Time (per SAM.gov response deadline)
What to include when you submit
- Submit a capability statement AND the attached Buy Indian Act Indian Economic Enterprise Representation Form
- Capability statement must directly demonstrate experience providing the JADA System or an equivalent FDA-cleared successor product; generic capability statements are not sufficient
You must have
- Preference given to Indian Economic Enterprises (IEE) under the Buy Indian Act
give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable.
Not in the notice text
- How and where to submit the capability statement (referenced as 'outlined below' but not shown in this text)
- Whether the eventual contract will be set aside further or opened more broadly
- Estimated quantity or contract value
- Period of performance
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Free during early access.
Key facts
- Response due
- Oct 5, 2026, 7:00 PM UTC
- Posted
- Sep 18, 2026
- Notice type
- Sources Sought
- Solicitation
- IHS102027
- Agency
- Department of Health and Human Services · Indian Health Service
- Office
- Indian Health Service
- Set-aside
- Buy Indian Set-Aside (specific to Department of Health and Human Services, Indian Health Services)
- NAICS
- 339112
- Product/service code
- 6515
- Business type
- Medical & healthcare
- Place of performance
- Oklahoma City, OK, 73114
- Contracting contact
- Mary Ann YochamMaryAnn.Yocham@ihs.gov4059516043
Full notice text from SAM.gov
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Pursuant to 48 CFR Part 326, Subpart 326.603-3 and IHM 5.5-6, the Indian Health Service (IHS) must use the negotiation authority of the Buy Indian Act, 25 U.S.C. 47, to give preference to Indian Economic Enterprises (IEE) whenever the use of that authority is authorized and practicable. The Government is seeking to identify Indian Small Business Economic Enterprises (ISBEEs) capable of performing the below Indian Health Service (IHS) requirement for JADA System (postpartum hemorrhage control device). Any vendor responding to this notice should submit their capability statement as well as the Buy Indian Act Indian Economic Enterprise Representation Form (attached). Instructions for submission are outlined below. Indian Small Business Economic Enterprises (ISBEEs) and other small business are highly encouraged to respond to this notice. However, firms should understand that generic capability statements are not sufficient for effective evaluation of their capacity and capability to perform the work required. Responses must directly demonstrate the company's capability, experience, and ability to provide new JADA System or equivalent FDA-cleared successor product. The delivery locations are: NSSC - DISTRIBUTION CENTER 501 NE 122nd St. Suite F Oklahoma City, OK 73114; NSSC I-35 8601 N I-35 Service Road Oklahoma City, OK 73131; NSSC-Gallup 2400 FUHS Avenue Building 10 Gallup, NM 87301.